Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy

NCT05029869 is registered in ClinicalTrials.gov with University Medical Center Ho Chi Minh City (UMC) as lead sponsor.

NCT NCT05029869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy
Lead sponsor
University Medical Center Ho Chi Minh City (UMC)
Phase
Observational
Overall status
Active, not recruiting
Start date
October 4, 2021
Completion date
December 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctdna, gastric cancer